Stock listing

Viva Biotech Holdings

Selected listing: A2PH5Q · LS · EUR · DE

Viva Biotech Holdings (Lang & Schwarz: A2PH5Q), Health Technology. Latest release Aug 26, 2026: Viva Biotech Announces Its 2026 Interim Results: AI Sparks New…

A2PH5Q:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A2PH5Q
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Viva Biotech Holdings

Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth

August 26, 2026

Viva Biotech Announces 2025 Annual Results: AI-Driven Drug Discovery Reinforces Industry Leadership, CDMO Commercial Products Enter Rapid Scale-Up

March 30, 2026

Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities

December 29, 2025

Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.

December 15, 2025

Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

September 29, 2025

All Viva Biotech Holdings news →

Research Viva Biotech Holdings

Viva Biotech Holdings company profile

View the public company page for Viva Biotech Holdings on 6ix.

Viva Biotech Holdings news

Read company news and market updates connected to Viva Biotech Holdings.

Viva Biotech Holdings investor events

Find investor webinars, events, and replay context for Viva Biotech Holdings.